Form 4: Arteris CEO Sells 40,000 Shares Under 10b5-1 Plan
Insider Transaction Report
Arteris, Inc. President and CEO K. Charles Janac sold 40,000 shares of common stock in late March 2026 through a pre-arranged 10b5-1 trading plan.
Summary
- K. Charles Janac, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported the sale of 40,000 shares of common stock.
- The sales occurred on March 25, 2026, and March 26, 2026.
- On March 25, 2026, 7,012 shares were sold at a weighted average price of $18.0309, with prices ranging from $18.00 to $18.08.
- On March 26, 2026, 32,988 shares were sold at a weighted average price of $18.3458, with prices ranging from $18.00 to $18.70.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Janac on March 5, 2025.
- Following these transactions, Mr. Janac beneficially owns 9,189,071 shares indirectly through Bayview Legacy, LLC, 217,538 shares directly, and 56,252 shares indirectly through the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction executed under a pre-arranged 10b5-1 plan, which mitigates concerns about opportunistic selling based on non-public information.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, adopted on March 5, 2025, which indicates the transactions were scheduled in advance and not based on immediate, non-public information, enhancing transparency.
Negatives
- The sale of 40,000 shares by the President and CEO reduces his direct beneficial ownership, which some investors might interpret as a slight decrease in management's direct equity alignment with shareholders.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
StockSavvy.ai notes that insider sales executed under Rule 10b5-1 trading plans are a common practice for executives to manage their personal finances while adhering to insider trading regulations. Such pre-scheduled sales are generally viewed as less indicative of management's immediate sentiment about the company's prospects compared to unplanned, open-market sales.
Related Party Transactions
- K. Charles Janac is the manager of Bayview Legacy, LLC, through which he indirectly beneficially owns 9,189,071 shares.
- K. Charles Janac serves as trustee for the Charles and Lydia Janac Trust, through which he indirectly beneficially owns 56,252 shares.
Stakeholder Impact
- Shareholders: The sale of shares by the CEO, even if pre-planned, slightly reduces the alignment of management's equity interests with shareholders. However, the pre-planned nature reduces the negative signal typically associated with insider selling.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date Rule 10b5-1 trading plan was adopted by K. Charles Janac. |
| 03/25/2026 | Date of first reported sale of 7,012 shares of Common Stock. |
| 03/26/2026 | Date of second reported sale of 32,988 shares of Common Stock. |
| 03/27/2026 | Date the Form 4 was signed by Paul Alpern, as Attorney-in-Fact for K. Charles Janac. |
Keywords
Arteris, AIP, Insider Trading, Form 4, Stock Sale, CEO, 10b5-1 Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.